Skip to content

Evaluation of TDCS for augmentation treatment of major depressive disorder with poor treatment response

Evaluation of TDCS for augmentation treatment of major depressive disorder with poor treatment response

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016012526189N1
Enrollment
30
Registered
2016-03-04
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder. Mild depressive episode

Interventions

Intervention 1: in case group:10 session of 20 minute of trans cranial direct current stimulation by 2 ma. Intervention 2: in control group:10 inactive session of 20 minutes by the same device.
Treatment - Other
in case group:10 session of 20 minute of trans cranial direct current stimulation by 2 ma
in control group:10 inactive session of 20 minutes by the same device

Sponsors

dr. Masud yunesian.manager of research affairs of Tehran University of Medical Sciencses
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient with MDD diagnosis due to DSM4 criteria; 20-60 years old; minimum education: 5 class; 8 week treatment by efficient dose of SSRIs and inappropriate response that reffer for TDCs by their psychiatrist plus drug treatment concurrently; probablity of bipolarity and medical problem such as hypothyroidism and acute social problem cause treatment resistance must be evaluate by psychiatrist befor study. Exclusin criteria: suicidal thought, psychosis, other psychiatric comorbidity except anxiety disorders; personality disorders, substance and alcohol abuse and dependency norologic disease( seizure, stroke, history of traumatic brain injury, life threatening problem in axis 3; metal things in brain or heart; pregnancy; lactation; disagreement to continue the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
?Depression rate. Timepoint: Before, immediately after and 3 months after treatment. Method of measurement: Hamilton depression rating scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsane Dadarkhah

AJA University of Medical Sciences

dadarkhah @yahoo.com+98 21 8802 8931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026